G-protein fusion receptors and chimeric gabab receptors
CA 2424546 A1 · Owner: Storjohann, Laura L. · Inventors: Hammerland, Lance G.; Busby, James G.; Storjohann, Laura L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention features G-protein fusion receptors and chimeric GABAB receptors (GABABRs), nucleic acid encoding such receptors and the use of such , receptors and nucleic acid. G-protein fusion receptors comprise at least one domain from a CaR, a mGluR, and/or a GABAB receptor fused directly or through a linker to a guanine nucleotide-binding protein (G-protein). Chimeric GABABRs comprise at least one of a GABABR extracellular domain a GABABR transmembrane , domain, or a GABABR intracellular domain and one or more domains from a mGluR subtype 8 (mGluR8) and/or a CaR.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 3, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 3, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 3, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.